探索基于UHPLC-HRMS,网络药理学和转录基因分析的清飞的潜在抗COPD成分和机制
Tong Zhang1, Zhuoqian Guo1, Tao Ma1
1School of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing 102488, China.
概括
清飞 (QFD) 通过减少肺炎,有效治疗慢性阻塞性肺病 (COPD). 这种传统中医药通过降低IL-17信号通路的调节来起作用,为呼吸系统疾病提供了一种新的治疗方法.
科学领域:
- 传统中国医药 传统中国医药
- 药理学 药理学是指药理学的学科.
- 呼吸系统医学 呼吸系统医学
背景情况:
- 清飞 (QFD) 是一种经典的传统中医 (TCM) 处方,广泛用于肺部疾病.
- 慢性阻塞性肺病 (COPD) 是一种普遍存在的呼吸道疾病,其特征是气道阻塞.
- 研究QFD的治疗效果,组件,点和COPD的途径至关重要.
研究的目的:
- 在弹性酶诱导的COPD小鼠模型中评估QFD的治疗疗效.
- 在COPD治疗中识别QFD的化学成分,潜在有效化合物,基因标和分子途径.
- 阐明QFD在缓解COPD症状中的作用机制.
主要方法:
- 超高性能液态染色学与高分辨率质谱学 (UHPLC-HRMS) 结合用于化学成分识别.
- 网络药理学预测基因标和有效化合物.
- 一种弹性酶诱导的COPD小鼠模型用于体内疗效评估,包括H&E,PAS染色,RT-qPCR,转录组分析,免疫光和西部斑.
主要成果:
- 鉴定了QFD的68种化学成分;预测有45种化合物对COPD有效.
- 网络药理学确定了30个基因标,其中IL-17信号通路被突出显示为主要标.
- 在COPD小鼠中,QFD治疗显著降低了炎症,证据是TRAF3IP2,TRAF6,IL17和TNFα的mRNA和蛋白质水平降低,证实了IL-17通路下调.
结论:
- QFD在治疗COPD方面显示出显著的治疗效果.
- 在COPD中,QFD的抗炎机制涉及IL-17信号通路的下调.
- QFD为COPD管理提供了一个有前途的治疗策略,得到了传统使用和现代科学研究的支持.
更多相关视频
13:18Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma
Published on: March 3, 2023
1.2K
11:06Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
Published on: April 7, 2023
1.9K
相关概念视频
COPD: Pathogenesis and Clinical Features
231
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
231
Antiasthma Drugs: Methylxanthines
195
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
195
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
COPD: Management Using Bronchodilators and Corticosteroids
177
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
177
